Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Shares Outstanding (Diluted Average) (2022 - 2025)

Avricore Health has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $72.6 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1.15% to $72.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.6 million through Dec 2025, up 1.15% year-over-year, with the annual reading at $72.5 million for FY2025, 1.06% down from the prior year.
  • Shares Outstanding (Diluted Average) was $72.6 million for Q4 2025 at Avricore Health, down from $73.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $77.2 million in Q2 2024 and troughed at $71.8 million in Q4 2024.
  • The 4-year median for Shares Outstanding (Diluted Average) is $73.9 million (2023), against an average of $74.2 million.
  • Year-over-year, Shares Outstanding (Diluted Average) rose 4.11% in 2024 and then dropped 5.32% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $72.1 million in 2022, then increased by 1.44% to $73.1 million in 2023, then dropped by 1.81% to $71.8 million in 2024, then rose by 1.15% to $72.6 million in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Shares Outstanding (Diluted Average) are $72.6 million (Q4 2025), $73.6 million (Q3 2025), and $73.1 million (Q2 2025).